Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Chronic-Phase trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Phase 3 Country / region: Germany Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Ascentage Pharma Group Inc.1
Bristol-Myers Squibb1
Fred Hutchinson Cancer Center1
German CML Study Group1
Heidelberg University1
III. Medizinische Klinik Mannheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase8
Leukemia4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Multiple Myeloma3
Waldenstrom Macroglobulinemia3
Blast Crisis2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.